Gynesonics snapped up in US$350m deal

Hologic is to acquire fellow femtech firm Gynesonics – which has developed minimally invasive solutions for women’s health – for US$350m.

Gynesonics, based in California, has developed the Sonata System, a technology intended for diagnostic intrauterine imaging and transcervical treatment of certain symptomatic uterine fibroids, including those associated with heavy menstrual bleeding. Hologic develops medtech aimed at detecting, diagnosing and treating women’s health conditions.

The acquisition is subject to customary closing conditions, including receipt of required regulatory approvals.

Brandon Schnittker, division president of surgical solutions at Hologic, said: “Gynesonics’ Sonata System complements our offering and will give GYN surgeons across the globe an expanded range of options to treat women suffering from heavy periods and fibroids.

“This acquisition furthers our commitment to providing women with minimally invasive treatment options. We are enthusiastic about the future as we work to expand access to and drive innovation for treatments that enhance women’s quality of life.”